Australian (16)
International (26)
Global
Regional / Country
Sector
Currency Hedged
Cash & Fixed Income (7)
Diversified (4)
Hybrids (1)
Equity Income (6)
Technology (7)
Ethical (7)
Geared (6)
Short (3)
Property (2)
Commodity (4)
Currency (5)
Managed Risk (3)
Active (8)
BetaShares Global Healthcare ETF - Currency Hedged
A simple and cost-effective way to gain exposure to a diversified portfolio of the world’s leading healthcare companies in a single ASX trade.
OVERVIEW
Fund Objective
DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
Benefits of DRUG
Healthcare – a global growth opportunity
Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.
Simple access to global healthcare giants
Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.
Cost-effective
Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.How to invest
- You can buy or sell units just like you’d buy or sell any share on the ASX.
- Fund requires no minimum investment.
KEY FACTS
Pricing Information 6 March 2021
| Current Price | |
|---|---|
| Last Trade* | - |
| % Change (prev day) | - |
| Bid (delayed) | - |
| Offer (delayed) | - |
* Data is delayed by at least 20 minutes.
Download NAV history
| NAV | |
|---|---|
| NAV/Unit* | $6.76 |
* As at 4 March 2021
Profile
| Net Assets* ($A) | $89,411,585 |
| Units Outstanding* (#) | 13,218,623 |
| Mgmt Costs** (% p.a.) | 0.57% |
| Distribution Frequency | Semi-annual |
| Distribution Reinvestment Plan (DRP) | Full or partial participation available |
| Issuer | BetaShares Capital Ltd |
| Fund Administrator | RBC Investor Services |
| Custodian | RBC Investor Services |
| Registry | Link Market Services |
| Auditor | KPMG |
* As at 4 March 2021
**Certain additional costs apply. Please refer to PDS.
Trading Information
| ASX Code | DRUG |
| Bloomberg Code | DRUG AU |
| IRESS Code | DRUG.AXW |
| Trading Hours | 10.00-16.00 (AEST) |
| iNAV IRESS Code | N/A |
| Market Makers | Deutsche Securities |
| SMSF Eligible | Yes |
Index Information
| Index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index |
| Index Provider | Nasdaq |
| Index Ticker | N/A |
| Bloomberg Index Ticker | NQXAUHHN Index |
Index Methodology
Portfolio Holdings
| Name | Weight (%) |
|---|---|
| JOHNSON & JOHNSON | 8.2 |
| UNITEDHEALTH GROUP INC | 6.1 |
| ROCHE HOLDING AG | 4.6 |
| ABBOTT LABORATORIES | 4.2 |
| NOVARTIS AG | 3.9 |
| ABBVIE INC | 3.8 |
| PFIZER INC | 3.7 |
| THERMO FISHER SCIENTIFIC INC | 3.6 |
| MERCK & CO INC | 3.5 |
| ELI LILLY AND CO | 3.4 |
| Ticker | Name | Weight (%) | Asset Class | Sector | Country | Currency | Shares/Unit (#) | Market Value (AUD) | Notional Value (AUD) |
|---|---|---|---|---|---|---|---|---|---|
| JNJ UN | JOHNSON & JOHNSON | 8.2 | Equities | Healthcare | United States | USD | 37,835 | $7,498,904 | $7,498,904 |
| UNH UN | UNITEDHEALTH GROUP INC | 6.1 | Equities | Healthcare | United States | USD | 12,955 | $5,599,519 | $5,599,519 |
| ROG SE | ROCHE HOLDING AG | 4.6 | Equities | Healthcare | Switzerland | CHF | 9,983 | $4,227,268 | $4,227,268 |
| ABT UN | ABBOTT LABORATORIES | 4.2 | Equities | Healthcare | United States | USD | 25,473 | $3,826,392 | $3,826,392 |
| NOVN SE | NOVARTIS AG | 3.9 | Equities | Healthcare | Switzerland | CHF | 32,690 | $3,561,379 | $3,561,379 |
| ABBV UN | ABBVIE INC | 3.8 | Equities | Healthcare | United States | USD | 25,374 | $3,471,142 | $3,471,142 |
| PFE UN | PFIZER INC | 3.7 | Equities | Healthcare | United States | USD | 75,892 | $3,360,749 | $3,360,749 |
| TMO UN | THERMO FISHER SCIENTIFIC INC | 3.6 | Equities | Healthcare | United States | USD | 5,696 | $3,255,932 | $3,255,932 |
| MRK UN | MERCK & CO INC | 3.5 | Equities | Healthcare | United States | USD | 34,544 | $3,228,073 | $3,228,073 |
| LLY UN | ELI LILLY AND CO | 3.4 | Equities | Healthcare | United States | USD | 12,099 | $3,141,698 | $3,141,698 |
| MDT UN | MEDTRONIC PLC | 3.0 | Equities | Healthcare | United States | USD | 18,356 | $2,739,733 | $2,739,733 |
| DHR UN | DANAHER CORP | 2.9 | Equities | Healthcare | United States | USD | 9,597 | $2,666,358 | $2,666,358 |
| BMY UN | BRISTOL-MYERS SQUIBB CO | 2.7 | Equities | Healthcare | United States | USD | 32,477 | $2,495,384 | $2,495,384 |
| NOVOB DC | NOVO NORDISK A/S | 2.6 | Equities | Healthcare | Denmark | DKK | 26,050 | $2,360,457 | $2,360,457 |
| AZN LN | ASTRAZENECA PLC | 2.3 | Equities | Healthcare | Britain | GBP | 17,352 | $2,140,553 | $2,140,553 |
| AMGN UW | AMGEN INC | 2.3 | Equities | Healthcare | United States | USD | 7,446 | $2,139,508 | $2,139,508 |
| SAN FP | SANOFI | 2.0 | Equities | Healthcare | France | EUR | 15,380 | $1,829,533 | $1,829,533 |
| GSK LN | GLAXOSMITHKLINE PLC | 1.6 | Equities | Healthcare | Britain | GBP | 67,064 | $1,477,013 | $1,477,013 |
| SYK UN | STRYKER CORP | 1.6 | Equities | Healthcare | United States | USD | 4,699 | $1,435,133 | $1,435,133 |
| ISRG UW | INTUITIVE SURGICAL INC | 1.5 | Equities | Healthcare | United States | USD | 1,537 | $1,411,361 | $1,411,361 |
| ANTM UN | ANTHEM INC | 1.5 | Equities | Healthcare | United States | USD | 3,360 | $1,398,688 | $1,398,688 |
| CI UN | CIGNA CORP | 1.5 | Equities | Healthcare | United States | USD | 4,777 | $1,389,122 | $1,389,122 |
| ZTS UN | ZOETIS INC | 1.4 | Equities | Healthcare | United States | USD | 6,830 | $1,273,495 | $1,273,495 |
| GILD UW | GILEAD SCIENCES INC | 1.4 | Equities | Healthcare | United States | USD | 15,134 | $1,239,056 | $1,239,056 |
| BDX UN | BECTON DICKINSON AND CO | 1.3 | Equities | Healthcare | United States | USD | 3,918 | $1,222,022 | $1,222,022 |
| BAYN GY | BAYER AG | 1.2 | Equities | Healthcare | Germany | EUR | 13,272 | $1,055,671 | $1,055,671 |
| 4502 JT | TAKEDA PHARMACEUTICAL CO LTD | 1.1 | Equities | Healthcare | Japan | JPY | 22,700 | $1,029,244 | $1,029,244 |
| BSX UN | BOSTON SCIENTIFIC CORP | 1.1 | Equities | Healthcare | United States | USD | 20,580 | $1,010,746 | $1,010,746 |
| 4568 JT | DAIICHI SANKYO CO LTD | 1.0 | Equities | Healthcare | Japan | JPY | 25,700 | $934,988 | $934,988 |
| PHIA NA | KONINKLIJKE PHILIPS NV | 1.0 | Equities | Healthcare | Netherlands | EUR | 13,094 | $917,615 | $917,615 |
| EW UN | EDWARDS LIFESCIENCES CORP | 1.0 | Equities | Healthcare | United States | USD | 8,510 | $902,239 | $902,239 |
| ILMN UW | ILLUMINA INC | 1.0 | Equities | Healthcare | United States | USD | 1,721 | $890,494 | $890,494 |
| EL FP | ESSILORLUXOTTICA SA | 1.0 | Equities | Consumer Discretionary | France | EUR | 4,286 | $890,149 | $890,149 |
| HUM UN | HUMANA INC | 0.9 | Equities | Healthcare | United States | USD | 1,655 | $833,243 | $833,243 |
| MRNA UW | MODERNA INC | 0.9 | Equities | Healthcare | United States | USD | 4,778 | $818,502 | $818,502 |
| LONN SE | LONZA GROUP AG | 0.9 | Equities | Healthcare | Switzerland | CHF | 1,070 | $812,115 | $812,115 |
| HCA UN | HCA HEALTHCARE INC | 0.9 | Equities | Healthcare | United States | USD | 3,550 | $810,575 | $810,575 |
| VRTX UW | VERTEX PHARMACEUTICALS INC | 0.9 | Equities | Healthcare | United States | USD | 2,915 | $784,291 | $784,291 |
| 7741 JT | HOYA CORP | 0.8 | Equities | Healthcare | Japan | JPY | 5,400 | $768,856 | $768,856 |
| IDXX UW | IDEXX LABORATORIES INC | 0.8 | Equities | Healthcare | United States | USD | 1,152 | $724,717 | $724,717 |
| BAX UN | BAXTER INTERNATIONAL INC | 0.7 | Equities | Healthcare | United States | USD | 6,901 | $682,862 | $682,862 |
| REGN UW | REGENERON PHARMACEUTICALS INC | 0.7 | Equities | Healthcare | United States | USD | 1,130 | $657,516 | $657,516 |
| BIIB UW | BIOGEN INC | 0.7 | Equities | Healthcare | United States | USD | 1,858 | $634,097 | $634,097 |
| 2269 HK | WUXI BIOLOGICS CAYMAN INC | 0.7 | Equities | Healthcare | China | HKD | 41,000 | $629,401 | $629,401 |
| ALC SE | ALCON INC | 0.7 | Equities | Healthcare | Switzerland | CHF | 7,031 | $616,706 | $616,706 |
| 2413 JT | M3 INC | 0.6 | Equities | Healthcare | Japan | JPY | 5,900 | $575,860 | $575,860 |
| ZBH UN | ZIMMER BIOMET HOLDINGS INC | 0.6 | Equities | Healthcare | United States | USD | 2,830 | $572,559 | $572,559 |
| DXCM UW | DEXCOM INC | 0.6 | Equities | Healthcare | United States | USD | 1,187 | $547,575 | $547,575 |
| 4503 JT | ASTELLAS PHARMA INC | 0.6 | Equities | Healthcare | Japan | JPY | 25,500 | $525,489 | $525,489 |
| CNC UN | CENTENE CORP | 0.6 | Equities | Healthcare | United States | USD | 6,750 | $518,202 | $518,202 |
| 4519 JT | CHUGAI PHARMACEUTICAL CO LTD | 0.6 | Equities | Healthcare | Japan | JPY | 9,700 | $518,114 | $518,114 |
| 4543 JT | TERUMO CORP | 0.5 | Equities | Healthcare | Japan | JPY | 9,500 | $460,824 | $460,824 |
| SGEN UW | SEAGEN INC | 0.5 | Equities | Healthcare | United States | USD | 2,333 | $439,382 | $439,382 |
| RMD UN | RESMED INC | 0.5 | Equities | Healthcare | United States | USD | 1,833 | $434,456 | $434,456 |
| 068270 KP | CELLTRION INC | 0.4 | Equities | Healthcare | South Korea | KRW | 1,108 | $389,043 | $389,043 |
| COLOB DC | COLOPLAST A/S | 0.4 | Equities | Healthcare | Denmark | DKK | 1,935 | $360,713 | $360,713 |
| FRE GY | FRESENIUS SE & CO KGAA | 0.4 | Equities | Healthcare | Germany | EUR | 5,849 | $324,270 | $324,270 |
| FME GY | FRESENIUS MEDICAL CARE AG & CO | 0.3 | Equities | Healthcare | Germany | EUR | 3,021 | $267,919 | $267,919 |
| 207940 KP | SAMSUNG BIOLOGICS CO LTD | 0.2 | Equities | Healthcare | South Korea | KRW | 238 | $203,941 | $203,941 |
| DIM FP | SARTORIUS STEDIM BIOTECH | 0.2 | Equities | Healthcare | France | EUR | 344 | $182,237 | $182,237 |
| AUD | AUD - AUSTRALIA DOLLAR | FX Forwards | AUD | 91,921,596 | $91,921,596 | ||||
| CHF | CHF - SWISS FRANC | FX Forwards | CHF | -6,707,751 | -$9,344,875 | ||||
| DKK | DKK - DANISH KRONE | FX Forwards | DKK | -13,325,746 | -$2,777,412 | ||||
| EUR | EUR - EURO | FX Forwards | EUR | -3,636,022 | -$5,635,496 | ||||
| GBP | GBP - BRITISH POUND | FX Forwards | GBP | -2,025,125 | -$3,643,294 | ||||
| HKD | HKD - HONG KONG DOLLAR | FX Forwards | HKD | -4,195,406 | -$700,051 | ||||
| JPY | JPY - JAPANESE YEN | FX Forwards | JPY | -422,232,508 | -$5,064,683 | ||||
| KRW | KRW - KOREAN WON | FX Forwards | KRW | -491,116,115 | -$562,615 | ||||
| USD | USD - UNITED STATES DOLLAR | FX Forwards | USD | -51,251,271 | -$66,361,868 |
Download CSV
* As at 4 March 2021. Excludes cash
Sector Allocation
| Pharmaceuticals | 45.0% |
* As of 29 January 2021
Country Allocation
| United States | 70.0% |
| Switzerland | 10.3% |
| Japan | 5.6% |
| Britain | 4.1% |
| France | 3.0% |
| Denmark | 2.8% |
| Germany | 1.8% |
| Netherlands | 1.0% |
| China | 0.8% |
| South Korea | 0.7% |
* As of 29 January 2021
PERFORMANCE
Fund Returns After Fees (%)
| Fund | Index | |
|---|---|---|
| 1 month | -2.57% | -2.47% |
| 3 months | 0.72% | 0.93% |
| 6 months | 1.62% | 1.87% |
| 1 year | 14.38% | 15.03% |
| 3 year p.a | 9.51% | 9.76% |
| 5 year p.a | - | 10.33% |
| Since inception (p.a) | 8.28% | 8.60% |
| Inception date | 4-Aug-16 | - |
* As at 26 February 2021
Chart
Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.
DISTRIBUTIONS
Yield Information
| Distribution Frequency | Semi-Annual |
| 12 Mth Distribution Yield* (%) | 0.8% |
| 12 Mth Gross Distribution Yield* (%) | - |
| Franking Level | - |
*As at 29 January 2021. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.
Recent Distributions
| Ex Date | Record Date | Payment Date | Distribution Unit ($) | Annual Distribution Return (%) (1) |
|---|---|---|---|---|
| 4-Jan-21 | 5-Jan-21 | 19-Jan-21 | $0.0166 | 1.00% |
| 1-Jul-20 | 2-Jul-20 | 16-Jul-20 | $0.04292 | 1.13% |
| 2-Jan-20 | 3-Jan-20 | 17-Jan-20 | $0.02494 | 0.46% |
| 2-Jan-19 | 3-Jan-19 | 17-Jan-19 | $0.01869 | 3.70% |
| 2-Jul-18 | 3-Jul-18 | 17-Jul-18 | $0.18445 | 3.77% |
| 2-Jan-18 | 3-Jan-18 | 17-Jan-18 | $0.01646 | 0.35% |
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.
RESOURCES
|
Factsheet - DRUG |
Download
|
|
|
Fund Flyer - DRUG |
Download
|
|
|
Portfolio Holdings |
Download
|
|
|
Product Disclosure Statement - Global Sector Series |
Download
|
|
|
Annual Report - June 2020 |
Download
|
|
|
NRWT and Fund Payment Notice information - December 2020 distributions |
Download
|
|
|
NRWT and Fund Payment Notice information - June 2020 distributions |
Download
|
|
|
Notice of Modifications to Fund Constitution – AMIT Tax Regime |
Download
|
|
|
Interim Financial Report 2018 |
Download
|
|
|
2020 BetaShares Distribution Calendar |
Download
|
View more